Proportion of All Patients Receiving a Monitoring Test
| Blood Pressure | Total Cholesterol | HbA1c | ||||
|---|---|---|---|---|---|---|
| Type of Cancer | History of Hypertension % (95% CI) | History of Diabetes % (95% CI) | History of CAD/MI % (95% CI) | History of Diabetes % (95% CI) | History of Cerebrovascular Disease % (95% CI) | History of Diabetes % (95% CI) |
| CAD=coronary artery disease; CI=confidence interval; HbA1c=glycated hemoglobin; MI=myocardial infarction. | ||||||
| a P <.05 for univariate χ2 comparison between cancer survivors and controls. | ||||||
| Breast | ||||||
| Survivor | 91.6a (90.8–92.4) | 90.7a (87.1–93.6) | 78.6a (74.7–82.0) | 84.4a (80.0–88.1) | 62.4a (55.8–68.7) | 86.2 (82.1–89.7) |
| Control | 95.2 (94.5–95.8) | 95.2 (92.3–97.2) | 86.9 (83.7–89.8) | 91.0 (87.4–93.9) | 81.7 (76.0–86.4) | 88.9 (85.1–92.1) |
| Colorectal | ||||||
| Survivor | 91.8a (90.4–93.1) | 89.8 (84.2–93.9) | 79.1a (75.2–82.6) | 79.6a (72.7–85.4) | 66.0a (58.0–73.4) | 83.2 (76.7–88.6) |
| Control | 95.4 (94.3–96.4) | 92.2 (87.0–95.8) | 87.5 (84.1–90.2) | 89.8 (84.2–93.9) | 80.7 (73.7–86.6) | 87.4 (81.4–92.0) |
| Prostate | ||||||
| Survivor | 88.9a (87.2–90.4) | 86.6a (80.6–91.3) | 79.2a (75.7–82.3) | 79.7a (72.9–85.4) | 64.2a (55.4–71.5) | 80.2a (73.5–85.9) |
| Control | 93.4 (92.0–94.6) | 94.2 (89.6–97.2) | 88.7 (85.8–91.1) | 89.5 (83.9–93.7) | 78.4 (70.9–84.7) | 90.1 (84.6–94.1) |